Financials

  • Market Capitalization 1.57 B
  • Employee 27
  • Founded 2015
  • CEO N/A
  • Website www.lbpharma.us
  • Headquarter Delaware, United States
  • FIGI BBG00XNP5MQ4
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-7.11
Rapporto prezzo/fatturato
77.13

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2174
XERS
Xeris Biopharma Holdings, Inc. - Common Stock
8.40 USD-2.33%-3.23%+2.07%+6.19%1.53 B USD
2179
TYRA
Tyra Biosciences, Inc. - Common Stock
25.32 USD-3.10%-4.60%-19.16%+76.57%1.51 B USD
2189
INVA
Innoviva, Inc. - Common Stock
20.98 USD+0.10%-0.38%-3.58%+17.73%1.52 B USD
2193
NVAX
Novavax, Inc. - Common Stock
9.00 USD-0.55%-0.77%+23.46%+19.05%1.48 B USD